Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 8, 2010, Pages 1456-1462

  Ihsan, Rakhshan ^a   Chattopadhyay, Indranil ^a   Phukan, Rupkumar ^b   Mishra, Ashwani K ^a   Purkayastha, Joydeep ^c   Sharma, Jagannath ^c   Zomawia, Eric ^d   Verma, Yogesh ^e   Mahanta, Jagadish ^b   Saxena, Sunita ^a   Kapur, Sujala ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b Regional Medical Research Center   (India)

^c Dr B Borooah Cancer Institute ^*  (India)

^d CIVIL HOSPITAL   (India)

^e Sir Thutop Namgyal Memorial Hospital   (India)

Author keywords

environmental exposure; epoxide hydrolase 1 gene polymorphism; esophageal cancer; north east India; polymorphism

Indexed keywords

EPOXIDE HYDROLASE; EPOXIDE HYDROLASE 1; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; ESOPHAGUS CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

EID: 77954934282     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06354.x     Document Type: Article

References (27)

1. Murtaza I, Mushtaq D, Margoob MA et al. A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J. Gastroenterol. 2006 12 : 4033 4037.
2. Katiyar S, Hedau S, Jain N et al. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett. 2005 218 : 69 79.
3. Kumar A, Chatopadhyay T, Raziuddin M, Ralhan R. Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray. Int. J. Cancer 2007 120 : 230 242.
4. Akbari MR, Malekzadeh R, Nasrollahzadeh D et al. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int. J. Cancer 2006 119 : 1047 1051.
5. Phukan RK, Ali MS, Chetia CK, Mahanta J. Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India. Br. J. Cancer 2001 85 : 661 667.
6. Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol. Appl. Pharmacol. 2008 230 : 247 251.
7. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CA. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br. J. Cancer 1999 79 : 168 171.
8. Lancaster JM, Brownlee HA, Bell DA et al. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol. Carcinog. 1996 17 : 160 162.
9. Voho A, Metsola K, Anttila S et al. EPHX1 gene polymorphisms and individual susceptibility to lung cancer. Cancer Lett. 2006 237 : 102 108.
10. Hassett C, Robinson KB, Beck NB, Omiecinski CJ. The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. Genomics 1994 433 442.
11. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 1994 3 : 421 428.
12. Zhou W, Thurston SW, Liu G et al. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol. Biomarkers. Prev. 2001 10 : 461 466.
13. Casson AG, Zheng Z, Chiasson D et al. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect. Prev. 2003 7 : 139 146.
14. Casson AG, Zheng Z, Porter GA et al. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Cancer Detect. Prev. 2006 30 : 423 431.
15. Zhang JH, Jin X, Li Y et al. Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of north China. World J. Gastroenterol. 2003 9 : 2654 2657.
16. Wang LD, Zheng S, Liu B, Zhou JX, Li YJ, Li JX. CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high- incidence area in north China. World J. Gastroenterol. 2003 9 : 1394 1397.
17. Chattopadhyay I, Phukan R, Singh A et al. Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering. Oncol. Rep. 2009 21 : 1135 1146.
18. Chattopadhyay I, Kapur S, Purkayastha J et al. Gene expression profile of esophageal cancer in North East India by cDNA microarray analysis. World J. Gastroenterol. 2007 13 : 1438 1444.
19. Lin YC, Wu DC, Lee JM et al. The association between microsomal epoxide hydrolase genotypes and esophageal squamous-cell-carcinoma in Taiwan: interaction between areca chewing and smoking. Cancer Lett. 2006 237 : 281 288.
20. Smith TJ, Liao A, Wang LD et al. Characterization of xenobiotic- metabolizing enzymes and nitrosamine metabolism in the human esophagus. Carcinogenesis 1998 19 : 667 672.
21. Amador AG, Righi PD, Radpour S et al. Polymorphisms of xenobiotic metabolizing genes in oropharyngeal carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2002 93 : 440 445.
22. Lebailly P, Willett EV, Moorman AV et al. Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities. Br. J. Haematol. 2002 116 : 587 594.
23. Sierra-Torres CH, Au WW, Arrastia CD et al. Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ. Mol. Mutagen. 2003 41 : 69 76.
24. Leng S, Dai Y, Niu Y et al. Effects of genetic polymorphisms of metabolic enzymes on cytokinesis-block micronucleus in peripheral blood lymphocyte among coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 2004 13 : 1631 1639.
25. Pastorelli R, Guanci M, Cerri A et al. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a) pyrene-diolepoxide. Cancer Epidemiol. Biomarkers Prev. 1998 7 : 703 709.
26. Kuljukka-Rabb T, Nylund L, Vaaranrinta R et al. The effect of relevant genotypes on PAH exposure-related biomarkers. J. Expo. Anal. Environ. Epidemiol. 2002 12 : 81 91.
27. Salama SA, Sierra-Torres CH, Oh HY, Hamada FA, Au WW. Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene. Environ. Mol. Mutagen. 2001 37 : 17 26.